Aua Inside Tract

In this episode of AUANews Inside Tract, Igniting Discovery, Kevin Eisenfrats, CEO of Contraline and 2025 Innovation Nexus Showcase winner, discusses the development of two novel male contraceptives, a daily hormonal gel (NEST) and a long-lasting, reversible implant (ADAM). He shares insights on clinical progress, regulatory strategy, and advice for innovators navigating the urology startup space through the AUA Innovation Nexus program.